Benzene compounds disubstituted with cyclic groups at the 1and 2-positions

Details for Australian Patent Application No. 2004309280 (hide)

Owner Eisai R and D Management Co., Ltd.

Inventors Ohkuro, Masayoshi; Yoneda, Naoki; Kotake, Makoto; Hirota, Shinsuke; Kawahara, Tetsuya

Agent Davies Collison Cave

Pub. Number AU-B-2004309280

PCT Pub. Number WO2005/063705

Priority 2003-434312 26.12.03 JP; 2003-435050 26.12.03 JP

Filing date 24 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 4 October 2007

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/452 (2006.01) - Piperidinium derivatives

A61K 31/4525 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063705 Priority application(s): WO2005/063705

25 January 2007 Assignment before Grant

  Eisai Co., Ltd. The application has been assigned to Eisai R and D Management Co., Ltd.

4 October 2007 Application Accepted

  Published as AU-B-2004309280

31 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309285-Process for purification of hemoglobin

2004309279-Thiazole derivative